A recent study conducted in Jordan showed that BRCA1/BRCA2 variants are common among Jordanian breast cancer patients as 27% of high-risk breast cancer patients had pathogenic or likely pathogenic variants in BRCA1 or BRCA2 genes9. This evidence concerns the gene BRCA1 and breast carcinoma.